Your browser doesn't support javascript.
loading
Low dose venetoclax as a single agent treatment of plasma cell malignancies harboring t(11;14).
Nahi, Hareth; Kashif, Muhammad; Klimkowska, Monika; Karvouni, Maria; Wallblom, Ann; Gran, Charlotte; Hauenstein, Julia; Frengen, Nicolai; Gustafsson, Charlotte; Afram, Gabriel; Uttervall, Katarina; Lund, Johan; Månsson, Robert; Wagner, Arnika K; Alici, Evren.
Afiliación
  • Nahi H; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Kashif M; Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
  • Klimkowska M; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Karvouni M; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Wallblom A; Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
  • Gran C; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Hauenstein J; Department of Clinical Pathology and Cytology, Karolinska University Hospital, Stockholm, Sweden.
  • Frengen N; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Gustafsson C; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Afram G; Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
  • Uttervall K; Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Lund J; Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
  • Månsson R; Department of Clinical Chemistry, Karolinska University Hospital, Stockholm, Sweden.
  • Wagner AK; Center for Hematology and Regenerative Medicine (HERM), Karolinska Institutet, Stockholm, Sweden.
  • Alici E; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Am J Hematol ; 96(8): 925-933, 2021 08 01.
Article en En | MEDLINE | ID: mdl-33901326
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Compuestos Bicíclicos Heterocíclicos con Puentes / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Sulfonamidas / Compuestos Bicíclicos Heterocíclicos con Puentes / Antineoplásicos Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Am J Hematol Año: 2021 Tipo del documento: Article País de afiliación: Suecia